Donepezil and Veltassa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Donepezil (donepezil hydrochloride) and Veltassa (patiromer sorbitex calcium). Common drug interactions include constipation among females and constipation among males.
The phase IV clinical study analyzes what interactions people have when they take Donepezil and Veltassa. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.
What is Donepezil?
Donepezil has active ingredients of donepezil hydrochloride. It is often used in dementia. eHealthMe is studying from 24,564 Donepezil users. Check the latest studies of Donepezil.
What is Veltassa?
Veltassa has active ingredients of patiromer sorbitex calcium. eHealthMe is studying from 15,649 Veltassa users. Check the latest studies of Veltassa.
74 people who take Donepezil and Veltassa together, and have interactions are studied.

What are the common drug interactions of Donepezil and Veltassa, by gender? *:
female:
- Constipation
- Weight increased
- Hospitalisation
- Death
- Abdominal pain upper
- Diarrhoea
- Malaise (a feeling of general discomfort or uneasiness)
- Abdominal pain
- Graft complication
- Pruritus (severe itching of the skin)
male:
- Constipation
- Ill-defined disorder
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Small intestinal obstruction (blockage in small intestine)
- Fall
- Abdominal discomfort
- Faecaloma (hard mass of fecal matter)
- Proctalgia (pain in the rectum)
- Renal failure (kidney dysfunction)
What are the common drug interactions of Donepezil and Veltassa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Constipation
60+:
- Constipation
- Death
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Small intestinal obstruction (blockage in small intestine)
- Diarrhoea
- Fall
- Abdominal discomfort
- Faecaloma (hard mass of fecal matter)
- Graft complication
What are the existing conditions these people have? *
- Hyperkalemia (damage to or disease of the kidney): 71 people, 95.95%
* Approximation only. Some reports may have incomplete information.
Do you take Donepezil and Veltassa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Donepezil and Veltassa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Donepezil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Veltassa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Donepezil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Veltassa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on donepezil hydrochloride and patiromer sorbitex calcium (the active ingredients of Donepezil and Veltassa, respectively), and Donepezil and Veltassa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pataday cause Pneumonia? - 18 seconds ago
- Drug interactions of Lidocaine Hydrochloride and Hydroxyzine - 20 seconds ago
- Could Robaxin cause Muscle Cramps? - 28 seconds ago
- Could Pregabalin cause Deformity? - 42 seconds ago
- Could Bumex cause Rashes? - 45 seconds ago
- Drug interactions of Risperidone and Fluoxetine - 54 seconds ago
- Could Linzess cause Atrial Fibrillation/Flutter? - a minute ago
- Could Risedronate Sodium cause Ulcerative Colitis? - a minute ago
- Could Ventolin cause Blood Glucose Fluctuation? - a minute ago
- Could Pantoprazole cause Fungal Nail Infection? - a minute ago